Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Why GSK May Have Bet Too Big on a Pandemic Pipeline
11:57am, Saturday, 07'th May 2022 The Motley Fool
Its late-stage pipeline is heavily weighted toward pandemic treatments.
Novavax: Don't Catch The Falling Knives
05:52am, Saturday, 07'th May 2022 Seeking Alpha
Novavax is scheduled to report its Q1 earnings on May 9. Read more to see why we think investors should avoid catching this falling knife.
Pfizer is looking beyond the COVID-19 market, aiming to be the 'partner of choice for biotech'
12:46pm, Friday, 06'th May 2022 MarketWatch
The company is already laying the groundwork for what it will look like when revenue from its COVID-19 franchise begins to wane.
2 Reasons Moderna Could Dominate the Long-Term Vaccine Market
10:00am, Friday, 06'th May 2022 The Motley Fool
Moderna's story may just be beginning.
Why Moderna Might Make Less Money This Year Than Everyone Expects
09:55am, Friday, 06'th May 2022 The Motley Fool
The company acknowledged that some of its projected revenue is at risk.
Where Moderna Stands With Analysts
02:03pm, Thursday, 05'th May 2022 Benzinga
Analysts have provided the following ratings for Moderna (NASDAQ:MRNA) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
0
4
2
0
Last 30
Several people who attended weekend White House correspondents dinner have since tested positive for COVID
10:17am, Thursday, 05'th May 2022 MarketWatch
A handful of people who attended the White House Correspondents' Dinner on Saturday night have tested positive for COVID-19.
This Prediction From Moderna's CEO Should Eliminate Investors' Biggest Worry
10:00am, Thursday, 05'th May 2022 The Motley Fool
Moderna delivers another billion-dollar quarter.
Why Moderna Stock Jumped Today
09:08pm, Wednesday, 04'th May 2022 The Motley Fool
COVID-19 vaccine sales are fueling the biotech's staggering growth.
Dow surges 900 points, books best day since 2020, after Fed takes 3/4-point rate hikes off table
08:34pm, Wednesday, 04'th May 2022 MarketWatch
Stocks end sharply higher Wednesday, after the Federal Reserve delivers a 50 basis-point interest rate hike, but says 75 basis-point increases aren't in play as it fights inflation.
Moderna (MRNA) Beats on Q1 Earnings, to Start Two Late Studies
03:39pm, Wednesday, 04'th May 2022 Zacks Investment Research
Moderna's (MRNA) Spikevax sales beat expectations. The company plans to start late-stage studies for Omicron-containing bivalent booster and seasonal flu vaccines later this year. Stock gains in pre-m
This Number in Moderna's Q1 Results Is a Game-Changer
03:02pm, Wednesday, 04'th May 2022 The Motley Fool
The old adage is correct: "Cash is king."
Markets are primed for how Powell will respond to this key question on interest rates
12:39pm, Wednesday, 04'th May 2022 MarketWatch
Investors are at the point now where they don't have to figure out what the Federal Reserve is going to do or what Chair Jerome Powell will say, they just need to know what it will do, and he will say
Moderna (MRNA) Q1 Earnings and Revenues Top Estimates
12:25pm, Wednesday, 04'th May 2022 Zacks Investment Research
Moderna (MRNA) delivered earnings and revenue surprises of 65.64% and 34.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
11:00am, Wednesday, 04'th May 2022 MarketWatch
The group rose at least 300% in the pandemic before crashing 70% or more.
